Average Sales Price Formula Could Produce Negative ASP, PhRMA Says
This article was originally published in The Pink Sheet Daily
Executive Summary
PhRMA recommends an alternative methodology that would "smooth out extreme fluctuations in ASP." The trade association proposes calculating the average ratio between rebates and sales revenue.
You may also be interested in...
Average Sales Price Final Rule Includes PhRMA's Estimation Method
Calculations of ASP for Medicare Part B drugs will be based on a rolling average percentage of price concessions divided by total sales, as proposed in manufacturers' comments. The final rule will be published Sept. 16.
Average Sales Price Final Rule Includes PhRMA's Estimation Method
Calculations of ASP for Medicare Part B drugs will be based on a rolling average percentage of price concessions divided by total sales, as proposed in manufacturers' comments. The final rule will be published Sept. 16.
Average Sales Price Formula Closely Follows Medicare Rx Law
The ASP final rule is scheduled to be published in the Federal Register April 6. CMS notes that the methodology may change in future years to include further price concessions.